EXPERIENCE IN OUR CENTER WITH THE USE OF RITUXIMAB - VENETOCLAX IN CHRONIC LYMPHOCYTIC LEUKEMIA

被引：0
|
作者：
Pimentel, Villar Ma [1 ]
De Leon, Marcano E. [1 ]
Jimenez, Moreno M. [1 ]
Lopez, Marquez T. J. [1 ]
Almagro, Torres F. [1 ]
Lopez, Lopez J. A. [1 ]
机构：
[1] Hosp Univ Jaen, Jaen, Spain
来源：
HAEMATOLOGICA | 2020年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB-049
引用
收藏
页码：389 / 390
页数：2
相关论文
共 50 条
  • [41] Treatment of relapsed chronic lymphocytic leukemia after venetoclax
    Thompson, Meghan C.
    Mato, Anthony R.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2020, (01) : 18 - 23
  • [42] Venetoclax and obinutuzumab for frontline treatment of chronic lymphocytic leukemia
    Stephens, Deborah M.
    BLOOD, 2019, 134 (20) : 1691 - 1696
  • [43] COVID-19 infection in chronic lymphocytic leukemia (CLL) patients treated with venetoclax: a Danish single-center experience
    Thau, Sophie
    Poulsen, Christian Bjorn
    Pedersen, Lars Moller
    LEUKEMIA & LYMPHOMA, 2023, 64 : S109 - S110
  • [44] Successful Retreatment With Venetoclax in a Patient With Chronic Lymphocytic Leukemia
    Jackson, Ross A.
    Smith, Victoria M.
    Jayne, Sandrine
    Drewes, Cosima
    Bens, Susanne
    Siebert, Reiner
    Dyer, Martin J. S.
    Walter, Harriet S.
    HEMASPHERE, 2022, 6 (08):
  • [45] Venetoclax: A Review in Relapsed/Refractory Chronic Lymphocytic Leukemia
    Lesley J. Scott
    Targeted Oncology, 2019, 14 : 493 - 504
  • [46] Venetoclax: A Review in Relapsed/Refractory Chronic Lymphocytic Leukemia
    Scott, Lesley J.
    TARGETED ONCOLOGY, 2019, 14 (05) : 493 - 504
  • [47] Combined Ibrutinib and Venetoclax for Patients With Chronic Lymphocytic Leukemia
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (02) : 16 - 17
  • [48] Chronic lymphocytic leukemia in Richter's transformation: Our experience.
    Belsito, VP
    Iaccarino, S
    Liguori, L
    Zecca, C
    Villani, O
    De Rienzo, M
    De Simone, G
    Garcia, M
    Abbadessa, A
    BLOOD, 1999, 94 (10) : 295B - 295B
  • [49] Prospect & progress of venetoclax in treating chronic lymphocytic leukemia
    Chitalia, Ami
    Ujjani, Chaitra
    EXPERT OPINION ON ORPHAN DRUGS, 2016, 4 (10): : 1087 - 1093
  • [50] Venetoclax in Patients with Previously Treated Chronic Lymphocytic Leukemia
    Roberts, Andrew W.
    Stilgenbauer, Stephan
    Seymour, John F.
    Huang, David C. S.
    CLINICAL CANCER RESEARCH, 2017, 23 (16) : 4527 - 4533
12345